文献速递角膜与眼表疾病

丁酸钠通过Nrf2/HO-1轴抗真菌并减轻炎症缓解真菌性角膜炎

Sodium Butyrate Alleviates Fungal Keratitis by Exerting Antifungal Activity and Dampening Inflammation Through the Nrf2/HO-1 Axis.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2026-01-01

本研究探讨丁酸钠(NaB)是否通过抗真菌与Nrf2/HO-1相关抗炎作用缓解烟曲霉菌性角膜炎。体外实验显示NaB抑制烟曲霉菌孢子萌发、生物膜形成并破坏真菌结构;小鼠模型中出现角膜真菌负荷下降、临床表现改善与炎症减轻,机制涉及Nrf2/HO-1通路激活及IL-6、IL-1β、TNF-α表达下降。

要点

  • NaB在不超过4 mM浓度下对RAW 264.7细胞、人角膜上皮细胞及小鼠眼表上皮未见明显毒性。
  • NaB体外抑制烟曲霉菌孢子萌发与生物膜形成,破坏真菌细胞壁和膜,并下调HSP90与RpdA。
  • 小鼠FK模型中NaB降低角膜真菌负荷、改善临床表现、减少炎症细胞浸润,并激活Nrf2/HO-1、降低IL-6、IL-1β、TNF-α。

核心结论

  • 丁酸钠在烟曲霉菌性角膜炎中发挥抗真菌和抗炎作用,支持其作为真菌性角膜炎治疗潜在药物的价值。

研究设计与样本

  • 体外实验评估NaB安全性及对烟曲霉菌的抗真菌活性,并在小鼠真菌性角膜炎模型中评估疗效与炎症反应。

主要发现

  • NaB在不超过4 mM时对RAW 264.7细胞、人角膜上皮细胞和小鼠眼表上皮未见明显毒性。
  • NaB抑制烟曲霉菌孢子萌发和生物膜形成,破坏真菌细胞壁与膜,减少孢子对上皮细胞的黏附,并下调HSP90和RpdA。
  • 电镜证实菌丝超微结构损伤;小鼠模型中NaB降低角膜真菌负荷、改善临床表现并减少炎症细胞浸润。
  • 机制上NaB激活Nrf2/HO-1通路并降低IL-6、IL-1β和TNF-α表达。

关键数值与推荐

  • NaB安全性评估浓度上限为4 mM,对象为RAW 264.7细胞、人角膜上皮细胞和小鼠眼表上皮。
  • 抗真菌活性采用最小抑菌浓度、结晶紫染色、碘化丙啶摄取、卡尔科弗卢白染色、孢子黏附实验及扫描与透射电镜评估。
  • HSP90与RpdA mRNA水平用qRT-PCR测定;小鼠模型疗效采用临床角膜评分、H&E染色和真菌平板计数评估。

临床怎么用

  • 提示NaB可能作为真菌性角膜炎的候选治疗药物,兼具直接抗真菌与Nrf2/HO-1介导的抗炎作用。
  • 临床转化前仍需进一步研究确定眼部给药方式、有效浓度与安全性。

局限性

  • 原文未报告临床人体研究数据,结论主要基于体外实验和小鼠模型。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The purpose of this study was to determine whether sodium butyrate (NaB) alleviates fungal keratitis (FK) through combined antifungal and Nrf2/HO-1-associated anti-inflammatory effects. METHODS: NaB safety was assessed by Cell Counting Kit-8 assays, scratch-wound assays, and fluorescein sodium staining. Antifungal activity against Aspergillus fumigatus (A. fumigatus) was evaluated by minimum inhibitory concentration assays, crystal violet staining, propidium iodide uptake, calcofluor white staining, conidial adhesion assays, and scanning and transmission electron microscopy. HSP90 and RpdA mRNA levels in A. fumigatus were measured by qRT-PCR. In a mouse FK model, therapeutic efficacy was examined by clinical corneal scoring, hematoxylin and eosin (H&E) staining, and fungal plate counts. The qRT-PCR, ELISA, and Western blotting were used to analyze inflammatory responses. RESULTS: NaB showed no overt toxicity in RAW 264.7 cells, human corneal epithelial cells, or mouse ocular surface epithelium at concentrations up to 4 mM. In vitro, NaB inhibited A. fumigatus conidial germination and biofilm formation, disrupted the fungal cell wall and membrane, reduced conidial adhesion to epithelial cells, and downregulated HSP90 and RpdA. Electron microscopy confirmed hyphal ultrastructural damage. In vivo, NaB decreased corneal fungal burden, improved clinical manifestations, and reduced inflammatory cell infiltration. Mechanistically, NaB activated the Nrf2/HO-1 pathway and decreased IL-6, IL-1β, and TNF-α expression. CONCLUSIONS: NaB exerts antifungal and anti-inflammatory effects in A. fumigatus keratitis, supporting its therapeutic potential for FK.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Zhang Z, Zhang Z, Duan H, et al. Sodium Butyrate Alleviates Fungal Keratitis by Exerting Antifungal Activity and Dampening Inflammation Through the Nrf2/HO-1 Axis. Invest Ophthalmol Vis Sci. 2026. PMID: 42954733. doi:10.1167/iovs.67.12.76

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。